On December 13, BNET Executive Director Peter Picarillo will present at the 2019 International Association of Emergency Managers (IAEM) Region 1 Conference at the University of Connecticut. The...

Parks Associates research shows 17% of insured homeowners in the US own at least one security-related device, apart from a home security system. The research firm will examine successful...

At COP25, Peter Fiekowsky, Founder and Chairman of the Foundation for Climate Restoration (F4CR) and Peter Wadhams, Professor Emeritus at the University of Cambridge, will present the solutions...

Lightwave Logic, Inc. (OTCQB: LWLG), a technology platform company leveraging its proprietary electro-optic polymers to transmit data at higher speeds with less power, today announced that...

Eisai announced today that new study results on its in-house discovered and developed anticancer agent eribulin mesylate (marketed as HALAVEN®) will be presented during the 42nd San Antonio...

Join us at SOLAR 20/20, a global solar event at the right place and at the right time. The events of the moment -- international pronouncements by international bodies of scientists on climate...

Senior Helpers®, the nation's premier provider of personalized in-home senior care, today announced it will host an educational session on caregiving techniques for dementia patients on January...

Converging Supply Chain Markets and Accelerated SaaS Adoption Drive Record-Breaking Momentum MONTREAL, Dec. 10, 2019 /PRNewswire/ -- Tecsys Inc. (TSX: TCS), an industry-leading supply chain...

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today results from the Phase 3 CANDOR study showing the addition of DARZALEX® (daratumumab) to carfilzomib (Kyprolis®) and...

Amgen (NASDAQ:AMGN) today announced additional results from the primary analysis of the Phase 3 CANDOR study evaluating KYPROLIS® (carfilzomib) in combination with dexamethasone and DARZALEX®...